Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study

British Journal of Psychiatry

Volumn 204, Issue 5, 2014, Pages 400-401

  Pietrzak, Robert H ^a   Scott, J Cobb ^a,b   Neumeister, Alexander ^c   Lim, Yen Ying ^d   Ames, David ^e,f   Ellis, Kathryn A ^e,f   Harrington, Karra ^d   Lautenschlager, Nicola T ^e,h   Szoeke, Cassandra ^d,i   Martins, Ralph N ^e   Masters, Colin L ^d,g   Villemagne, Victor L ^d,k   Rowe, Christopher C ^j,k   Maruff, Paul ^d,k  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h CSIRO   (Australia)

ⁱ EDITH COWAN UNIVERSITY   (Australia)

^j National Ageing Research Institute Mental Health Research Institute University of Melbourne ^*  (United States)

^k Scientific Division   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; ANXIETY DISORDER; ARTICLE; BRAIN; COHORT ANALYSIS; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENTAL DETERIORATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; VERBAL MEMORY; VISUAL MEMORY; AGED; AGING; ANXIETY; FEMALE; MALE; MEMORY; MEMORY DISORDERS; METABOLISM; PSYCHOLOGY; SCINTISCANNING;

AGED; AGING; AMYLOID BETA-PEPTIDES; ANXIETY; BRAIN; COHORT STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 84899735109     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.113.134239     Document Type: Article

References (10)

1. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999; 45: 358-68.
2. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010; 31: 1275-83.
3. Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, et al. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology 2012; 79: 1645-52.
4. Lavretsky H, Siddarth P, Kepe V, Ercoli LM, Miller KJ, Burggren AC, et al. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults. Am J Geriatr Psychiatry 2009; 17: 493-502.
5. Ramakers IHGB, Verhey FRJ, Scheltens P, Hampel H, Soininen H, Aalten P, et al. Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychol Med 2013; 43: 911-20.
6. Murrough JW, Iacoviello B, Neumeister A, Charney DS, Iosifescu DV. Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem 2011; 96: 553-63.
7. Eysenck MW, Derakshan N, Santos R, Calvo MG. Anxiety and cognitive performance: attentional control theory. Emotion 2007; 7: 336-53.
8. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
9. Harrington K, Lim YY, Ellis KA, Copolov C, Ames D, Darby D, et al. The association of Ab amyloid and composite cognitive measures in healthy older adults and MCI. Int Psychogeriatr 2013; 25: 1667-77.
10. Beaudreau SA, O'Hara R. Late-life anxiety and cognitive impairment: a review. Am J Geriatr Psychiatry 2008; 16: 790-803.